Lichen planus and chronic hepatitis C: Exacerbation of the lichen under interferon-alpha-2a therapy

European Journal of Gastroenterology and Hepatology

Volumn 8, Issue 8, 1996, Pages 825-828

  Areias, Jorge ^a,b   Velho, Glória C ^a   Cerqueira, Rute ^a   Barbêdo, Carla ^a   Amaral, Barbas ^a   Sanches, Madalena ^a   Massa, António ^a   Saraiva, Amílcar Mascarenhas ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b HOSPITAL DE SANTO ANTÓNIO   (Portugal)

Author keywords

Hepatitis C; Interferon 2a; Lichen planus

Indexed keywords

AMINOTRANSFERASE; ANTIVIRUS AGENT; RECOMBINANT ALPHA2A INTERFERON;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CASE REPORT; CHRONIC HEPATITIS; DISEASE SEVERITY; DRUG EFFICACY; HEPATITIS C; HISTOLOGY; HUMAN; LICHEN PLANUS; MALE; PRIORITY JOURNAL; SIDE EFFECT;

ANTIVIRAL AGENTS; CHRONIC DISEASE; DISEASE PROGRESSION; HEPATITIS C; HUMANS; INTERFERON ALFA-2A; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED;

EID: 0029832494     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Alter MJ, Mast EE: The epidemiology of viral hepatitis in the United States. Gastroenterol Clin North Am 1994, 23:437-455.
2. Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, et al.: Recombinant interferon alpha therapy for chronic hepatitis. N Engl J Med 1989, 321:1506-1510.
3. Davis GL, Balard LA, Schiff ER, Lindsay K, Bodenheimer JC, Perillo RP, et al.: Treatment of chronic hepatitis C with recombinant interferon alpha: a multicenter randomized, controlled trial. N Engl J Med 1989, 321:1501-1506.
4. Davis GL: Recombinant alpha-interferon treatment of NANB (type C) hepatitis: review of studies and recommendations for treatment. J Hepatol 1990, 11(suppl. 1):72-77.
5. Marcellin P, Boyer N, Giostra E, Degott C, Couroucé AM, Degos F, et al.: Recombinant human alpha-interferon in patients with chronic NANB hepatitis: a multicenter randomized controlled trial from France. Hepatology 1991, 101:497-502.
6. Protzer U, Ochsendorf FR, Leopolder-Ochsendorf A, Holtermüller K-H: Exacerbation of lichen planus during interferon alpha-2a therapy for chronic active hepatitis C. Gastroenterology 1993, 104:903-905.
7. Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED): Lichen planus and liver diseases: a multicentre case-control study. BMJ 1990, 300:227-230.
8. Pawlotsky J-M, Ben Yahia M, Andre C, Voisin M-C, Intrator L, Roudot-Thoraval F, et al.: Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994, 19:841-848.
9. Jubert C, Pawlotsky J-M, Pouget F, André C, Deforges L, Bretagne S, et al.: Lichen planus and hepatitis C virus-related chronic active hepatitis. Arch Dermatol 1994, 130:73-76.
10. Grandolfo S, Carbone M, Carrozzo M: Oral lichen planus and hepatitis C virus (HCV) infection: is there a relationship? A report of 10 cases. J Oral Pathol Med 1994, 23:119-122.
11. Koff RS, Dienstag JL: Extrahepatic manifestations of hepatitis C and the association with alcoholic liver disease. Semin Liver Dis 1995, 15:101-109.
12. Rebora A, Rougioletti F: Lichen planus and chronic active hepatitis: a retrospective survey. Acta Derm Venereol 1984, 64:52-56.
13. Korkij W, Chuang TY, Soltani K: Liver abnormalities in patients with lichen planus: a retrospective case-control study. J Am Acad Dermatol 1984, 11:609-615.
14. Samman PD: Lichen planus: an analysis of 200 cases. Trans Rep St John's Hosp Dermatol Soc London 1961, 46:36-38.
15. Boyd AS, Neldner KH: Lichen planus. J Am Acad Dermatol 1991, 25:593-619.
16. Mayet W-J, Hess C, Gerken G, Rossol S, Voth R, Manns M, et al.: Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis. Hepatology 1989, 10:24-28.
17. Rodrigues B, Oliviera M, Inock A: Licken plan induit par interféron alpha 2b chez un malade avec un myélome à IgG. Nouv Dermatol 1989, 8:29-31.
18. D'Agay-Absensour L, Benamonzig R, de Belilovsky C, Cordoliani F, Halphen M, Rambaud JC: Licken plan au cours d'une hepatite viral chronique C traitée par interféron alpha. Gastroenterol Clin Biol 1992, 16:610-611.
19. Sassigneux P, Michel P, Joly P, Colin R: Licken plan cutanéomuqueux éruptif au cours du traitement d'une hépatite C chronique par interféron alpha. Gastroenterol Clin Biol 1993, 17:764.
20. Doutre MS, Beylot C, Couzigou P, Royer P, Beylot J: Lichen planus and virus C hepatitis: disappearance of the lichen under interferon alpha therapy. Dermatology 1992, 184:229.
21. Griffiths CE, Voorhees JJ, Nickloff BJ: Characterisation of intracellular adhesion molecule-1 and HLA-DR expression in normal and inflammated skin: modulation by recombinant gamma interferon and tumor necrosis factor. J Am Acad Dermatol 1989, 20:617-629.
22. Thomas HC: The hepatitis B virus and the host response. J Hepatol 1990, 11(suppl. 1):S83-S89.